for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Big Pharma, Small M&A Returns

Posted

April 21 - Rob Cox and Robert Cyran discuss why Pfizer shareholders may come to appreciate AstraZeneca’s reported refusal of a $101 billion bid from the U.S. drugs giant.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up